Pliant Therapeutics, Inc. SEC filings PLRX
Pliant Therapeutics, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jul 20, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Mar 30, 2026 | — |
| S-8 | Employee stock plan registration | Mar 11, 2026 | — |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2024 | — |
| S-3ASR | Automatic shelf registration | Mar 27, 2023 | — |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| 424B5 | Prospectus supplement | Jan 25, 2023 | — |
| S-3MEF | Filing | Jan 24, 2023 | — |
| 424B5 | Prospectus supplement | Jan 23, 2023 | — |
| 424B5 | Prospectus supplement | Jul 14, 2022 | — |
| 424B5 | Prospectus supplement | Jul 11, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| POS AM | Filing | Mar 1, 2022 | — |
| S-3ASR | Automatic shelf registration | Jul 2, 2021 | — |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| S-8 | Employee stock plan registration | Jun 4, 2020 | — |
| 424B4 | Prospectus | Jun 3, 2020 | — |
| S-1/A | Amended registration statement | Jun 2, 2020 | — |
| S-1/A | Amended registration statement | May 26, 2020 | — |
| S-1 | Registration statement | May 11, 2020 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PLRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1746473
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.